Does TAXOTERE Cause Interstitial lung disease? 7 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Interstitial lung disease have been filed in association with TAXOTERE. This represents 3.1% of all adverse event reports for TAXOTERE.
7
Reports of Interstitial lung disease with TAXOTERE
3.1%
of all TAXOTERE reports
3
Deaths
4
Hospitalizations
How Dangerous Is Interstitial lung disease From TAXOTERE?
Of the 7 reports, 3 (42.9%) resulted in death, 4 (57.1%) required hospitalization, and 2 (28.6%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAXOTERE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does TAXOTERE Cause?
Diarrhoea (22)
Nausea (21)
Dyspnoea (18)
Disease progression (15)
Febrile neutropenia (13)
Mucosal inflammation (13)
Pyrexia (13)
Neutropenia (12)
Asthenia (10)
Pleural effusion (10)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TAXOTERE Alternatives Have Lower Interstitial lung disease Risk?
TAXOTERE vs TAZAROTENE
TAXOTERE vs TAZEMETOSTAT
TAXOTERE vs TAZEMETOSTAT HYDROBROMIDE
TAXOTERE vs TAZOBACTAM
TAXOTERE vs TBO-FILGRASTIM